Abdul Samad, Z., and A. Jameel. “FDA Approves Axatilimab: A New Standard in Chronic Graft-Versus-Host Disease Therapy”. Journal of the Pakistan Medical Association, vol. 75, no. 12, Nov. 2025, pp. 2010-1, doi:10.47391/JPMA.25-22322.